Rebecca J Conaughton1, Caroline L Donovan2, Sonja March3. 1. School of Applied Psychology, Menzies Health Institute Queensland, Mount Gravatt Campus, Mount Gravatt, QLD 4122, Australia. Electronic address: rebecca.conaughton@griffithuni.edu.au. 2. School of Applied Psychology, Menzies Health Institute Queensland, Mount Gravatt Campus, Mount Gravatt, QLD 4122, Australia. Electronic address: c.donovan@griffith.edu.au. 3. School of Psychology and Counselling, Institute for Resilient Regions, University of Southern Queensland, Springfield Campus, Springfield, Qld 4432, Australia.
Abstract
BACKGROUND: All trials conducted to date on BRAVE-ONLINE for youth anxiety disorders have excluded children with High Functioning Autism Spectrum Disorder (HFASD) and therefore it is unknown whether these programs might be beneficial to HFASD children. The aim of this study was to evaluate the efficacy of BRAVE-ONLINE in HFASD children with an anxiety disorder. METHODS:Forty-two HFASD children, aged 8-12 years, with an anxiety disorder, and their parents, were randomly assigned to either the BRAVE-ONLINE condition (NET) or a waitlist control (WLC). Diagnostic interviews and parent/child questionnaires were completed at pre-treatment, post-treatment and 3-month follow-up. RESULTS: At post- assessment, compared to children in the WLC condition, children in the NET condition demonstrated a significantly greater reduction in number of anxiety diagnoses, clinical severity of diagnosis, and self and parent reported anxiety symptoms, as well as significantly greater increases in overall functioning. However, loss of primary diagnosis in this sample was lower than in previous studies. LIMITATIONS: The small sample size, coupled with attrition rates, makes it difficult to generalise the findings of the study to HFASD population and to conduct analyses regarding mediators, moderators and predictors of outcomes. CONCLUSIONS: The BRAVE-ONLINE program may be useful in reducing anxiety symptoms in HFASD children, although the effects are less strong than those found in neurotypical children for a variety of reasons.
RCT Entities:
BACKGROUND: All trials conducted to date on BRAVE-ONLINE for youth anxiety disorders have excluded children with High Functioning Autism Spectrum Disorder (HFASD) and therefore it is unknown whether these programs might be beneficial to HFASD children. The aim of this study was to evaluate the efficacy of BRAVE-ONLINE in HFASD children with an anxiety disorder. METHODS: Forty-two HFASD children, aged 8-12 years, with an anxiety disorder, and their parents, were randomly assigned to either the BRAVE-ONLINE condition (NET) or a waitlist control (WLC). Diagnostic interviews and parent/child questionnaires were completed at pre-treatment, post-treatment and 3-month follow-up. RESULTS: At post- assessment, compared to children in the WLC condition, children in the NET condition demonstrated a significantly greater reduction in number of anxiety diagnoses, clinical severity of diagnosis, and self and parent reported anxiety symptoms, as well as significantly greater increases in overall functioning. However, loss of primary diagnosis in this sample was lower than in previous studies. LIMITATIONS: The small sample size, coupled with attrition rates, makes it difficult to generalise the findings of the study to HFASD population and to conduct analyses regarding mediators, moderators and predictors of outcomes. CONCLUSIONS: The BRAVE-ONLINE program may be useful in reducing anxiety symptoms in HFASD children, although the effects are less strong than those found in neurotypical children for a variety of reasons.
Authors: Ashley D Radomski; Lori Wozney; Patrick McGrath; Anna Huguet; Lisa Hartling; Michele P Dyson; Kathryn Bennett; Amanda S Newton Journal: J Med Internet Res Date: 2019-02-05 Impact factor: 5.428
Authors: Kareem Khan; Charlotte L Hall; E Bethan Davies; Chris Hollis; Cris Glazebrook Journal: J Med Internet Res Date: 2019-11-01 Impact factor: 5.428
Authors: Ashley D Radomski; Lori Wozney; Patrick McGrath; Anna Huguet; Lisa Hartling; Michele P Dyson; Kathryn J Bennett; Amanda S Newton Journal: JMIR Ment Health Date: 2019-10-23
Authors: Hong Ji Pi; Kannan Kallapiran; Shashidhara Munivenkatappa; Preeti Kandasamy; Richard Kirubakaran; Paul Russell; Valsamma Eapen Journal: J Autism Dev Disord Date: 2021-07-27